Bank Of America Corp Sesen Bio, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.0 - $0.93 $0 - $22,031	23,690 Added 869.68%	26,414 $11,000
Q2 2022 Aug 12, 2022	SELL	$0.38 - $0.89 $5,637 - $13,204	-14,836 Reduced 84.49%	2,724 $2,000
Q1 2022 May 16, 2022	SELL	$0.58 - $0.86 $13,235 - $19,625	-22,820 Reduced 56.51%	17,560 $11,000
Q4 2021 Feb 08, 2022	BUY	$0.73 - $1.28 $7,989 - $14,009	10,945 Added 37.18%	40,380 $33,000
Q3 2021 Nov 15, 2021	SELL	$0.77 - $4.91 $4,532 - $28,900	-5,886 Reduced 16.66%	29,435 $23,000
Q2 2021 Sep 13, 2021	BUY	$2.18 - $4.66 $76,999 - $164,595	35,321 New	35,321 $163,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.